John Weinberg, MD, COO, Veloxis Pharmaceuticals, describes the benefits of the Veloxis’ Envarsus, an orphan drug for the treatment of organ transplant rejection. Envarsus is a reformulation of tacrolimus,…
John Weinberg, MD, COO, Veloxis Pharmaceuticals describes the challenges of organ transplantation. While advancements in the field have minimized the short-term risks of transplantation, the average kidney transplant only lasts…
John Weinberg, MD, COO, Veloxis Pharmaceuticals, talks about the challenges in current organ transplantation methods, and Veloxis’ once-daily solution to advancing kidney transplantation. According to Weinberg, most kidney transplants…
Hair loss affects nearly 50% of people in the US and across the world. Those who suffer from hair loss may lack expression of genes regulated hair growth.…
Hair loss, both the more medical forms and more conventional forms, affects many millions of people in the US and across the world. Current treatments include “accidental” drug…
HIV infection attacks the immune system. In many parts of Africa, patients with HIV infection, also have vitamin deficiencies. A new study examined whether giving a multivitamin and…
Researchers at a university in eastern Zhejiang Province have used a 3D printer to create living kidneys, which are expected to be used for transplants in the future.
Salim Ismail, Founding Executive Director, Singularity University, gives you the top 5 medical breakthroughs by 2020 that will revolutionize medicine in the healthcare sector. Read more about Salim…